JK07

(別名: SAL007)

JK07 (SAL007) is a conjugate of an antagonistic HER3 antibody and the EGF-binding domain of NRG-1. JK07 utilizes the NRG1 EGF-like domain to stimulate ErbB4 phosphorylation and HER2/HER4 dimerization and activate AKT signaling, while its antibody component antagonizes ErbB3, blocking NRG-1-induced HER3 dimerization and reducing ErbB3-mediated toxicity. JK07 enhances angiogenesis, reduces cardiac fibrosis and type I Collagen deposition, and improves cardiac function after myocardial infarction. JK07 improves left ventricular ejection fraction and attenuates left ventricular dilation in heart failure models. JK07 can be used for research on coronary microvascular dysfunction and head and neck squamous cell carcinoma.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

  • 保管条件:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • 生物活性
  • 化学情報
  • プロトコル
  • 純度とドキュメンテーション
  • 参考文献
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

お問い合わせ 在庫あり

Other size
お問い合わせ
Please select quantity
Amount: USD 0.00